Wednesday, July 18, 2018
 
 
Company News: Page (1) of 1 - 06/19/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Yoichiro Ito, MD, Recognized for Development of Cancer Chemical Separation Method
Dr. Ito holds 50 patents for numerous chromatographic advances
(June 19, 2018)

ROCKVILLE, Md., June 19, 2018 /PRNewswire/ --Yoichiro Ito, MD, is a distinguished biographee of Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are chosen from among a pool of the most prominent professionals and are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

A respected voice in the scientific community, Dr. Ito serves as a senior investigator and pathologist with the Laboratory of Bioseparation Technology at the National Institutes of Health. In this position, he is noted for numerous innovations in the field of separation science, including the continuous development of a countercurrent chromatography and cell separation method. Dr. Ito is also involved with a continuous-flow cell separation method based on cell density, spiral disk assembly and spiral assembly for high-speed countercurrent chromatography and chiral countercurrent chromatography. However, he considers the greatest highlight of his career to have been the development of numerous purification methods from the coil planet centrifuge.



Since the inception of his career, Dr. Ito has obtained 50 patents for numerous chromatographic advances, such as the coil planet centrifuge, rotating-seal-free flow-through centrifuge, pH-zone-refining countercurrent chromatography and centrifugal precipitation chromatography. In addition, he has contributed more than 600 articles to professional journals pertaining to his areas of expertise. Dr. Ito has also been featured in a wide range of honors publications, including Who's Who in America, Who's Who in Medicine and Healthcare, Who's Who in the East and Who's Who in the World. He was most recently selected to receive the FLC Mid-Atlantic Region's Award for Excellence in Technology Transfer for high-speed countercurrent chromatography in 2010.

Upon receiving a Doctor of Medicine from Osaka City University in 1958, Dr. Ito completed an internship through the United States Naval Hospital in Yokosuka, Japan. He went on to complete residencies in pathology through the Cleveland Metropolitan General Hospital and then Michael Reese Hospital in Chicago. Early in his career, Dr. Ito briefly served as an instructor of physiology with the Graduate School of Medicine at Osaka City University. He joined the National Heart, Lung and Blood Institute as a visiting scientist with the National Institutes of Health in 1968. After completing 10 years of service, Dr. Ito was recognized as a medical officer of the National Institutes of Health in 1978.

About Marquis Who's Who:

Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America, Marquis Who's Who has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis publications may be visited at the official Marquis Who's Who website at www.marquiswhoswho.com.

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/yoichiro-ito-md-recognized-for-development-of-cancer-chemical-separation-method-300668487.html

SOURCE Marquis Who's Who

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:USA,Science,Cancer,Business,Entertainment,Politics,Science,
Related Sites: Hollywood Industry ,   DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Implantable Medical Devices Market Predicted to be Worth US$ 49.8 Bn by 2024, Says TMR
  • Global Cosmetic Chemicals Industry
  • HMP's 8th Annual Amputation Prevention Symposium Expected to Draw 800 Clinicians to Chicago to Join the CLI Revolution
  • Progressive Care Inc. Announces Month-End Sales Figures Showing Increase in Year-Over-Year Prescriptions Filled in June 2018

    Cancer
  • Camurus Announces PDUFA Date for CAM2038 for the Treatment of Opioid use Disorder
  • Presage Biosciences Closes Series D Financing with Takeda and Celgene, and Announces Appointment of Richard Klinghoffer, PhD as Chief Executive Officer
  • Presage Biosciences Closes Series D Financing with Takeda and Celgene, and Announces Appointment of Richard Klinghoffer, PhD as Chief Executive Officer
  • Corporate Whistleblower Center Now Targets Hospice Providers Ripping Off Medicare And Urges Their Employees with Proof a of Wrongdoing to Call About Rewards -- Don't Get Mad, Get Even
  • Corporate Whistleblower Center Now Targets Hospice Providers Ripping Off Medicare And Urges Their Employees with Proof a of Wrongdoing to Call About Rewards -- Don't Get Mad, Get Even
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines